Montelukast
Product Sizes
50 mg
£216.00
SIH-538-50MG
250 mg
£256.00
SIH-538-250MG
About this Product
- SKU:
- SIH-538
- Additional Names:
- 1-[[[(1R)-1-[3-(1E)-2-(7-chloro-2-quinolinyl)ethenyl]phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]thio]-methyl]-cyclopropaneacetic acid, monosodium salt, Montelukast sodium, Montelukast monosodium salt, MK-0476, MK-476, KS-1087
- CAS Number:
- 151767-02-1
- CE/IVD:
- Not for use in humans. Not for use in diagnostics or therapeutics. For in vitro research use only.
- Extra Details:
- Montelukast sodium, a selective cysteinyl leukotriene receptor 1 (CysLT1) antagonist, is gaining attention in neuroscience for its neuroprotective and anti-inflammatory properties. Originally developed for asthma and allergic rhinitis, Montelukast has demonstrated the ability to cross the blood-brain barrier and modulate neuroinflammatory responses. In preclinical models, it has been shown to reduce blood-brain barrier disruption, inhibit leukocyte migration, and suppress seizure activity. These effects suggest potential therapeutic applications in neurodegenerative diseases such as Alzheimer's and Parkinson's, where inflammation and barrier dysfunction are key pathological features.
- Molecular Weight:
- 608.2
- Purity:
- >98%
- Shipping Conditions:
- Ambient
- Source:
- Synthetic
- Storage Conditions:
- -20[o]C
- Supplier:
- StressMarq Biosciences
- Type:
- Proteins, Peptides, Small Molecules & Other Biomolecules: Inhibitors
- Manufacturer's Data Sheet:https://www.stressmarq.com/products/small-molecules/antagonist/montelukast-sodium-sih-538/
